Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer

Gastric cancer remains a significant global health burden, characterized by regional variations in incidence and poor survival prospects in advanced stages. Natural killer (NK) cells play a crucial role in the body’s anti-cancer defense, and chimeric antigen receptor (CAR)–NK cell therapy is gaining...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaojun Ren, Min Xue, Xinhui Hui, Xiuyu Liu, Muhammad Asad Farooq, Yiran Chen, Yuzhou Ji, Yixin Duan, Iqra Ajmal, Jie Yao, Wenzheng Jiang
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825000623
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199393151647744
author Yaojun Ren
Min Xue
Xinhui Hui
Xiuyu Liu
Muhammad Asad Farooq
Yiran Chen
Yuzhou Ji
Yixin Duan
Iqra Ajmal
Jie Yao
Wenzheng Jiang
author_facet Yaojun Ren
Min Xue
Xinhui Hui
Xiuyu Liu
Muhammad Asad Farooq
Yiran Chen
Yuzhou Ji
Yixin Duan
Iqra Ajmal
Jie Yao
Wenzheng Jiang
author_sort Yaojun Ren
collection DOAJ
description Gastric cancer remains a significant global health burden, characterized by regional variations in incidence and poor survival prospects in advanced stages. Natural killer (NK) cells play a crucial role in the body’s anti-cancer defense, and chimeric antigen receptor (CAR)–NK cell therapy is gaining attention as a cutting-edge and promising treatment method. This study aims to tackle the challenge of TGF-β-mediated tumor immune evasion within the immunosuppressive tumor microenvironment by designing a novel chimeric cytokine receptor TRII/21 R, which consists of extracellular domains of TGF-β receptor II (TRII) and transmembrane and intracellular domains of IL-21 receptor (21 R) and can convert the immunosuppressive signal from TGF-β in the tumor microenvironment (TME) into an NK cell activation signal through the IL-21R-STAT3 pathway. We successfully constructed NKG2D-CAR-NK cells expressing TRII/21 R and demonstrated strong anti-tumor activity against cancer cells both in vitro and in vivo. The co-expression of TRII/21 R in CAR-NK cells enhanced the cytotoxicity, promoted proliferation and survival capabilities, and reduced the expression of exhaustion markers. In the xenograft mouse model, TRII/21R-CAR-NK cells significantly inhibited tumor growth and improved the survival rate of tumor-bearing mice compared to the mice receiving control CAR-NK cells. Additionally, TRII/21 R co-expression enhanced NK cells' infiltration, activation, and persistence within the tumor, indicating a robust anti-tumor response mediated by the JAK-STAT3 signaling pathway. This study underscores the therapeutic potential of TRII/21R-modified CAR-NK cells as a breakthrough strategy for combating cancer.
format Article
id doaj-art-162f96f9ed964aa3b6436f88a17fbe91
institution Kabale University
issn 1096-1186
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-162f96f9ed964aa3b6436f88a17fbe912025-02-08T04:59:56ZengElsevierPharmacological Research1096-11862025-02-01212107637Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancerYaojun Ren0Min Xue1Xinhui Hui2Xiuyu Liu3Muhammad Asad Farooq4Yiran Chen5Yuzhou Ji6Yixin Duan7Iqra Ajmal8Jie Yao9Wenzheng Jiang10Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; College of Life Science, Xinjiang Normal University, Urumqi 830054, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, ChinaShanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; Correspondence to: School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.Gastric cancer remains a significant global health burden, characterized by regional variations in incidence and poor survival prospects in advanced stages. Natural killer (NK) cells play a crucial role in the body’s anti-cancer defense, and chimeric antigen receptor (CAR)–NK cell therapy is gaining attention as a cutting-edge and promising treatment method. This study aims to tackle the challenge of TGF-β-mediated tumor immune evasion within the immunosuppressive tumor microenvironment by designing a novel chimeric cytokine receptor TRII/21 R, which consists of extracellular domains of TGF-β receptor II (TRII) and transmembrane and intracellular domains of IL-21 receptor (21 R) and can convert the immunosuppressive signal from TGF-β in the tumor microenvironment (TME) into an NK cell activation signal through the IL-21R-STAT3 pathway. We successfully constructed NKG2D-CAR-NK cells expressing TRII/21 R and demonstrated strong anti-tumor activity against cancer cells both in vitro and in vivo. The co-expression of TRII/21 R in CAR-NK cells enhanced the cytotoxicity, promoted proliferation and survival capabilities, and reduced the expression of exhaustion markers. In the xenograft mouse model, TRII/21R-CAR-NK cells significantly inhibited tumor growth and improved the survival rate of tumor-bearing mice compared to the mice receiving control CAR-NK cells. Additionally, TRII/21 R co-expression enhanced NK cells' infiltration, activation, and persistence within the tumor, indicating a robust anti-tumor response mediated by the JAK-STAT3 signaling pathway. This study underscores the therapeutic potential of TRII/21R-modified CAR-NK cells as a breakthrough strategy for combating cancer.http://www.sciencedirect.com/science/article/pii/S1043661825000623Chimeric cytokine receptorCAR-NKTGF-βIL-21Gastric cancerImmunosuppressive tumor microenvironment
spellingShingle Yaojun Ren
Min Xue
Xinhui Hui
Xiuyu Liu
Muhammad Asad Farooq
Yiran Chen
Yuzhou Ji
Yixin Duan
Iqra Ajmal
Jie Yao
Wenzheng Jiang
Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
Pharmacological Research
Chimeric cytokine receptor
CAR-NK
TGF-β
IL-21
Gastric cancer
Immunosuppressive tumor microenvironment
title Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
title_full Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
title_fullStr Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
title_full_unstemmed Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
title_short Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
title_sort chimeric cytokine receptor tgf β rii il 21r improves car nk cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
topic Chimeric cytokine receptor
CAR-NK
TGF-β
IL-21
Gastric cancer
Immunosuppressive tumor microenvironment
url http://www.sciencedirect.com/science/article/pii/S1043661825000623
work_keys_str_mv AT yaojunren chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT minxue chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT xinhuihui chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT xiuyuliu chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT muhammadasadfarooq chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT yiranchen chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT yuzhouji chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT yixinduan chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT iqraajmal chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT jieyao chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer
AT wenzhengjiang chimericcytokinereceptortgfbriiil21rimprovescarnkcellfunctionbyreversingtheimmunosuppressivetumormicroenvironmentofgastriccancer